CD103+ cDC1 and endogenous CD8+ T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function
CD40L-expressing chimeric antigen receptor (CAR) T cells show enhanced anti-tumor immunity, but the cellular mechanisms are still unclear. Here we show, by analyzing mice deficient of conventional dendritic cell type 1 (cDC1) that cDC1s are induced by CD40L+ CAR T cells to prime endogenous CD8 T cel...
Guardado en:
Autores principales: | Nicholas F. Kuhn, Andrea V. Lopez, Xinghuo Li, Winson Cai, Anthony F. Daniyan, Renier J. Brentjens |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/73e25f98128942e1a7488cf2c4e6a8e9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
por: Thomas Duhen, et al.
Publicado: (2018) -
TGFβR signalling controls CD103+CD11b+ dendritic cell development in the intestine
por: C. C. Bain, et al.
Publicado: (2017) -
CAR T-Cell Therapy: Is CD28-CAR Heterodimerization Its Achilles’ Heel?
por: Leonardo M. R. Ferreira, et al.
Publicado: (2021) -
CD40-signalling abrogates induction of RORγt+ Treg cells by intestinal CD103+ DCs and causes fatal colitis
por: Christian Barthels, et al.
Publicado: (2017) -
Erratum: CD40-signalling abrogates induction of RORγt+ Treg cells by intestinal CD103+ DCs and causes fatal colitis
por: Christian Barthels, et al.
Publicado: (2017)